The proportion of patients with lung carcinoma that harbors EGFR mutation varies globally with 6% reported in African American patients, 15% in Europeans, 23% in Indians, 35% in Hispanics and 47% in Asians [3, 4]. Here, EGFR is linked to lung carcinoma.